Intrapericardial bleomycin may lead to arrhythmia

Citation
I. Rohrer et al., Intrapericardial bleomycin may lead to arrhythmia, ONKOLOGIE, 22(1), 1999, pp. 57-58
Citations number
6
Categorie Soggetti
Oncology
Journal title
ONKOLOGIE
ISSN journal
0378584X → ACNP
Volume
22
Issue
1
Year of publication
1999
Pages
57 - 58
Database
ISI
SICI code
0378-584X(199902)22:1<57:IBMLTA>2.0.ZU;2-S
Abstract
Background: Malignant pericardial effusion can lead to cardiac tamponade. T he condition is treated with drainage often followed by intrapericardial in stillation of a sclerosing agent such as bleomycin. No major side effects l ike arrhythmia have been reported after intrapericardial instillation of bl eomycin, Case Report: We describe the case of clinically relevant, although transient atypical atrial flutter 6 hours after intrapericardial instillat ion of 30 mg of bleomycin in a patient with malignant effusion due to metas tatic breast cancer. The arrhythmia subsided after 12 hours and has not rec urred during the following 9 months. Conclusions: 30 mg of intrapericardial bleomycin may lead to atrial arrhythmia. Smaller doses of bleomycin have b een reported not to be arrhythmogenic and may be equally effective.